Show simple item record

dc.contributor.authorAhinko, Mira
dc.contributor.authorKurkinen, Sami
dc.contributor.authorNiinivehmas, Sanna
dc.contributor.authorPentikäinen, Olli
dc.contributor.authorPostila, Pekka
dc.date.accessioned2019-06-18T11:35:39Z
dc.date.available2019-06-18T11:35:39Z
dc.date.issued2019
dc.identifier.citationAhinko, M., Kurkinen, S., Niinivehmas, S., Pentikäinen, O., & Postila, P. (2019). A Practical Perspective : The Effect of Ligand Conformers on the Negative Image-Based Screening. <i>International Journal of Molecular Sciences</i>, <i>20</i>(11), Article 2779. <a href="https://doi.org/10.3390/ijms20112779" target="_blank">https://doi.org/10.3390/ijms20112779</a>
dc.identifier.otherCONVID_31222556
dc.identifier.otherTUTKAID_81710
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/64677
dc.description.abstractNegative image-based (NIB) screening is a rigid molecular docking methodology that can also be employed in docking rescoring. During the NIB screening, a negative image is generated based on the target protein’s ligand-binding cavity by inverting its shape and electrostatics. The resulting NIB model is a drug-like entity or pseudo-ligand that is compared directly against ligand 3D conformers, as is done with a template compound in the ligand-based screening. This cavity-based rigid docking has been demonstrated to work with genuine drug targets in both benchmark testing and drug candidate/lead discovery. Firstly, the study explores in-depth the applicability of different ligand 3D conformer generation software for acquiring the best NIB screening results using cyclooxygenase-2 (COX-2) as the example system. Secondly, the entire NIB workflow from the protein structure preparation, model build-up, and ligand conformer generation to the similarity comparison is performed for COX-2. Accordingly, hands-on instructions are provided on how to employ the NIB methodology from start to finish, both with the rigid docking and docking rescoring using noncommercial software. The practical aspects of the NIB methodology, especially the effect of ligand conformers, are discussed thoroughly, thus, making the methodology accessible for new users.fi
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherMDPI Center
dc.relation.ispartofseriesInternational Journal of Molecular Sciences
dc.rightsCC BY 4.0
dc.subject.othercyclooxygenase-2 (COX-2)
dc.subject.otherdocking rescoring
dc.subject.othermolecular docking
dc.subject.othernegative image-based (NIB) screening
dc.subject.othernegative image-based rescoring (R-NiB)
dc.subject.otherrigid docking
dc.subject.otherstructure-based drug discovery
dc.subject.othervirtual screening
dc.titleA Practical Perspective : The Effect of Ligand Conformers on the Negative Image-Based Screening
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-201906183266
dc.contributor.laitosBio- ja ympäristötieteiden laitosfi
dc.contributor.laitosDepartment of Biological and Environmental Scienceen
dc.contributor.oppiaineSolu- ja molekyylibiologiafi
dc.contributor.oppiaineNanoscience Centerfi
dc.contributor.oppiaineCell and Molecular Biologyen
dc.contributor.oppiaineNanoscience Centeren
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.date.updated2019-06-18T09:15:32Z
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1661-6596
dc.relation.numberinseries11
dc.relation.volume20
dc.type.versionpublishedVersion
dc.rights.copyright© 2019 by the authors.
dc.rights.accesslevelopenAccessfi
dc.subject.ysomolekyylilääketiede
dc.subject.ysolääkesuunnittelu
dc.subject.ysoentsyymit
dc.subject.ysoligandit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p23456
jyx.subject.urihttp://www.yso.fi/onto/yso/p25180
jyx.subject.urihttp://www.yso.fi/onto/yso/p4769
jyx.subject.urihttp://www.yso.fi/onto/yso/p24741
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.3390/ijms20112779
dc.type.okmA1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0